Germany· DE-A57-c844a8557e87c6b3
Calcipotriderm Comp.
A medicinal product containing betamethasone dipropionate, calcipotriol monohydrate, registered in Germany by Dermapharm Ag.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Betamethasone Dipropionate, Calcipotriol Monohydrate
- Manufacturer
- Dermapharm Ag
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Betamethasone dipropionate, calcipotriol monohydrate in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenCalcipotriol/Betamethasone Abacus Medicine 50 mikrogram/g + 0,5 mg/g SalvaAbacus Medicine A/S
- United KingdomCalcipotriol 0.005% / Betamethasone dipropionate 0.05% gelAccord-UK Ltd
- SwitzerlandCalcipotriol-Betamethason-Mepha
- SpainCALCIPOTRIOL/BETAMETASONA ARISTO 50 MICROGRAMOS/G + 0,5 MG/G GELAristo Pharma Gmbh
- NetherlandsCalcipotriol/Betamethason Aristo 50 microgram/g + 0,5 mg/g, gelAristo Pharma GmbH
- United StatesAtteroPerfero Pharma, Inc.
- ItalyARIBEC*ARISTO PHARMA GMBH
- IrelandCalcipotriol/Betamethasone 50 microgram/g + 0.5 mg/g gelAristo Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Aribec, Calcidermetha
- Belgium · Crysalis, Dovobet
- Bulgaria · Дайвобет, Енстилар
- Cyprus · Dοvobet, Enstilar
- Czechia · Enstilar, Talizon
- Denmark · Calcipotriol/Betamethasone "sandoz", Calcipotriol/Betamethasone Aristo
- Estonia · Cabemet, Daivobet
- Spain · Calcipotriol/Betametasona Aristo, Calcipotriol/Betametasona Ratiopharm
- Finland · Calcipotriol/Betamethasone Sandoz, Daivobet
- France · Calcipotriol/Betamethasone Sandoz, Closalis
- United Kingdom (Northern Ireland) · Calcipotriol/Betamethasone, Calcipotriol/Betamethasone Sandoz
- Greece · Dοvobet, Enstilar
- Croatia · Daivobet, Enstilar
- Hungary · Daivobet, Enstilar
- Ireland · Calcipotriol/Betamethasone, Calcipotriol/Betamethasone Rowex
- Iceland · Daivobet, Enstilar
- Italy · Aribec, Calbeta
- Lithuania · Cabemet, Daivobet
- Luxembourg · Calcipotriol Comp, Closalis
- Latvia · Cabemet, Daivobet
- Malta · Cabemet, Daivobet
- Netherlands · Calcipotriol/Betamethason Aristo, Calcipotriol/Betamethason Sandoz
- Norway · Calcipotriol/Betamethasone Aristo, Calcipotriol/Betamethasone Orifarm
- Poland · Betacal, Daivobet
- Portugal · Betametasona + Calcipotriol Aristo, Closalis
- Romania · Daivobet, Enstilum
- Sweden · Calcipotriol/Betamethasone Aristo, Calcipotriol/Betamethasone Orifarm
- Slovenia · Daivobet, Enstilum
- Slovakia · Daivobet, Enstilar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c6cdb196-8615-4106-a4d0-b5e8fa8b37d8 GET /v1/drugs/c6cdb196-8615-4106-a4d0-b5e8fa8b37d8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Cutaneous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Betamethasone Dipropionate, Calcipotriol Monohydrate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about betamethasone dipropionate, calcipotriol monohydrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.